Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114654) titled 'Dynamic study of cfDNA in peripheral blood in early-stage cervical cancer' on Dec. 16, 2025.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Zhejiang Cancer Hospital
Condition:
HPV-related cervical cancer
Intervention:
Early-stage (stage I-II) cervical cancer patients :N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Early-stage (stage I-II) cervical cancer patients :180;Healthy control group :20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=300548
Discl...